|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials.
|
29911392 |
2020 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
So we evaluated the efficacy of the prasugrel/ticagrelor in patients with myocardial infarction (MI) and diabetes, a more high-risk patients group.From the Korea Acute Myocardial Infarction Registry-National Institute of Health, 3985 patients with MI and diabetes who underwent PCI were enrolled between November 2011 and December 2015.
|
30882670 |
2019 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
At 36 months MV PCI was associated with similar incidence of the composite endpoint (all-cause death, non-fatal myocardial infarction [MI], ACS-driven, revascularisation, or stroke) in both Cox proportional hazards model (hazard ratio [HR] 1.26; 95% confidence interval [CI] 0.75-2.11; p = 0.39) and propensity matched analysis (HR 1.28; 95% CI 0.75-2.21; p = 0.36).
|
30251246 |
2019 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
Background Timely revascularization with percutaneous coronary intervention ( PCI ) reduces death following myocardial infarction.
|
31092091 |
2019 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
Key secondary outcome was the rate of suboptimal post- PCI Thrombolysis in Myocardial Infarction ( TIMI ; flow grade 0-2).
|
30764687 |
2019 |
|
SERPINA5
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We then analyzed post-PCI cardiac troponin level to adjudicate PMI based on the third universal definition of myocardial infarction.
|
29112510 |
2018 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
FFR-guided PCI was associated with better clinical outcomes regarding the reduction of myocardial infarction and major adverse cardiac events.
|
30917220 |
2018 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
OCT-guided PCI in comparison with angiography-guided was associated with reduction in adverse events for the composite of cardiac deaths, myocardial infarction and repeat revascularizations.
|
29151138 |
2018 |
|
SERPINA5
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The primary device-oriented endpoint (Target Lesion Failure, TLF) was defined as a combination of cardiovascular death, target vessel myocardial infarction or clinically driven target lesion revascularization.Among the cardiac risk factors, NSTE-ACS patients were more frequently smokers (P = 0.028), had less frequently dyslipidemia (P = 0.003) and a history of prior PCI (P < 0.01).The median follow-up was 1070[763-1197] days.
|
29630530 |
2018 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
During a follow-up period of 365 days after initial PCI, all patients were tracked for a primary endpoint, defined as a combined endpoint consisting of either time to death, myocardial infarction (MI) or ischemic stroke.
|
29867494 |
2018 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
We used landmark analyses starting 1 year after the index PCI to assess the risk of prolonged DAPT on the primary endpoint of death or MI.
|
27860195 |
2017 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
Regarding shock, preliminary data suggests that a concept of early left ventricular unloading before PCI maybe the critical factor for improving the outcome for acute myocardial infarction complicating myocardial infarction.
|
28856523 |
2017 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
We compared cardiac death, target lesion revascularisation (TLR), myocardial infarction (MI) and combined major adverse cardiac events (MACE) in patients with successful versus failed PCI (median follow-up 4.2 years).
|
27890859 |
2017 |
|
SERPINA5
|
0.100 |
Biomarker
|
disease |
BEFREE |
Complications included coronary dissection, cardiac tamponade, death, Q-wave myocardial infarction (MI), non-Q-wave MI, emergency PCI and bypass surgery.
|
27875729 |
2017 |